SERMlike
SERMlike is a term used to describe medications that mimic the effects of Selective Estrogen Receptor Modulators (SERMs) but may not be classified as true SERMs. These compounds interact with estrogen receptors in the body, acting as agonists or antagonists in a tissue-specific manner. This means they can produce estrogen-like effects in some tissues while blocking estrogen's effects in others. This targeted action is a key characteristic that differentiates them from traditional hormone replacement therapies, which affect all estrogen receptors throughout the body.
The development and study of SERMlike compounds are driven by the potential to achieve therapeutic benefits